Long COVID’s biological blueprint: new study offers promising insights

Researchers designed a cross-sectional study to investigate the biological underpinnings of “Long COVID”, the post-acute infection syndrome triggered by SARS-CoV-2.

PeptiDream, Genentech enter peptide-RI drug conjugate discovery deal

The latest deal comes after the companies entered into a multi-target partnership and licence agreement in December 2015. Credit: Mongkolchon Akesin/Shutterstock.com Japan-based biopharmaceutical company PeptiDream

September 20, 2023

Harnessing the untapped potential of medicines access – Pharmaceutical Technology

Share this article When it comes to medicines access, numerous factors may delay or prevent medical products from reaching patients. It is the role of

January 25, 2024

Fungal Cell Cultures Bloom with Benefits for Manufacturers

By Gail Dutton Cell lines represent a particularly tight bottleneck in biomanufacturing. Conventional cell lines—such as those used in CHO, bacterial, and baculovirus–insect cell expression

June 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.